Drug ID:   | NPD9390 |
Drug Name:   | LA-419 |
Molecular Formula:   | C8H11NO6S |
Canonical SMILES:   | O=N(=O)O[C@@H]1CO[C@H]2[C@@H]1OC[C@@H]2SC(=O)C |
Standard InCHI:   | InChI=1S/C8H11NO6S/c1-4(10)16-6-3-14-7-5(15-9(11)12)2-13-8(6)7/h5-8H,2-3H2,1H3/t5-,6+,7-,8-/m1/s1 |
Standard InCHIKey:   | BXZDULYKEZVEEK-ULAWRXDQSA-N |
Max Developmental Stage:   | Phase 2 |
Max Developmental Stage Source:   | TTD |
Similarity level is defined by Tanimoto coefficient (Tc) between two molecules. Tc lies between [0, 1] where '1' indicates the highest similarity. What is Tanimoto coefficient
Tanimoto coefficient is calculated based on PubChem 881-bit substructure fingerprints.
High Similarity Level: Tc>=0.85; Intermediate Similarity Level: 0.7 <= Tc < 0.85; Remote Similarity Level: 0.65 <= Tc < 0.7
Similarity Level | Similarity Score | Natural Product ID |
---|---|---|
Intermediate Similarity | 0.7037 | NPC85078 |
Remote Similarity | 0.6667 | NPC112363 |
Remote Similarity | 0.5741 | NPC325038 |
Remote Similarity | 0.5692 | NPC326557 |
Remote Similarity | 0.5676 | NPC320012 |
TTD   | DIB002463 |
DrugBank   | |
ChEMBL   | |
IUPHAR/BPS   | |
PharmaGKB   | |
KEGG Drug   | |
PubChem CID   | |
ChEBI   | |
CAS Number   |
Molecular Weight   | 249.03 |
ALogP   | -0.0238 |
MLogP   | 1.46 |
XLogP   | 0.064 |
HDA   | 3 |
HBD   | 0 |
Rotatable Bonds   | 5 |
TPSA   | 115.88 |
RO5 Violation   | 0 |